Hepatitis C virus and liver transplantation: where do we stand?-Reference-Cited by-同舟云学术

Hepatitis C virus and liver transplantation: where do we stand?

Published:2015-08-11 Issue:2 Volume:29 Page:135-152
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Burra Patrizia¹,De Martin Eleonora¹²,Zanetto Alberto¹,Senzolo Marco¹,Russo Francesco Paolo¹,Zanus Giacomo³,Fagiuoli Stefano⁴

Affiliation:

1. Multivisceral Transplant Unit, Gastroenterology; Department of Surgery, Oncology and Gastroenterology; Padua University Hospital; Padua Italy

2. Centre Hepato-Biliaire Paul Brousse; Villejuif France

3. Hepatobiliary Surgery and Liver Transplantation Unit; Department of Surgery, Oncology and Gastroenterology; Padua University Hospital; Padua Italy

4. Gastroenterology and Transplant Hepatology; Papa Giovanni XXIII Hospital; Bergamo Italy

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12642/fullpdf

Reference146 articles.

1. Ledipasvir/Sofosbuvir with ribavirin for the treatment of HCV in patients with decompensated cirrhosis: preliminary results of a prospective, multicenter study;Flamm;Hepatology,2014

2. Natural history of recurrent hepatitis C;Berenguer;Liver Transpl,2002

3. Hepatitis C genotype influences post-liver transplant outcomes;Campos-Varela;Transplantation,2015

4. Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis;Verna;Liver Transpl,2013

5. Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation;Ercolani;Liver Transpl,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical benefits of direct‐acting antivirals therapy in hepatitis C virus patients with hepatocellular carcinoma: A systematic review and meta‐analysis;Journal of Gastroenterology and Hepatology;2022-06-30

2. Safety and efficacy of sofosbuvir‐based medication regimens with and without ribavirin in hepatitis C patients: A systematic review and meta‐analysis;Journal of Clinical Pharmacy and Therapeutics;2022-06-08

3. CAQ Corner: Disease recurrence after liver transplantation;Liver Transplantation;2022-05-26

4. Revolution in the diagnosis and management of hepatitis C virus infection in current era;World Journal of Hepatology;2022-04-27

5. Hepatitis C virus eradication with direct‐acting antiviral improves insulin resistance;Journal of Viral Hepatitis;2019-12-02